Dr Lysa Charles, MD | |
2101 E Jefferson St Ppqa Medicare Compliance Unt 6 West, Kaiser Permanente Mid Atlantic Permanente Medical Group, Rockville, MD 20852-4908 | |
(301) 816-6660 | |
(301) 816-6308 |
Full Name | Dr Lysa Charles |
---|---|
Gender | Female |
Speciality | Orthopedic Surgery |
Experience | 33 Years |
Location | 2101 E Jefferson St Ppqa Medicare Compliance Unt 6 West, Rockville, Maryland |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1497832083 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | D0053807 (Maryland) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
News Archive
Researchers have developed a method by which thousands of men with prostate cancer could choose their own treatment.
According to a recent analysis by SDI, a leading healthcare market insight and analytics firm, about half of patients beginning therapy on popular osteoporosis drugs discontinue their treatment within 6 months. Amgen's Prolia, which was recently approved for postmenopausal women with osteoporosis at high risk of fracture, or patients who could not tolerate other osteoporosis therapies, is the newest product to enter the market. Prolia differs from existing therapies as it is given every 6 months via injection.
A familiar critique of liberal governance is that the results always matter less than its grand social ambitions. The latest evidence of this truth comes in the reaction to disappointing new findings from one of the most important public-policy experiments since the 1970s. A team of varsity health economists, mostly at Harvard and MIT, is studying the relationship between health outcomes and health insurance delivered by Medicaid (5/2).
The U.S. Food and Drug Administration today warned four companies that the caffeine added to their malt alcoholic beverages is an "unsafe food additive" and said that further action, including seizure of their products, is possible under federal law.
Long before symptoms of Alzheimer's disease become apparent to patients and their families, biological changes are occurring within the brain. Amyloid plaques, which are clusters of protein fragments, along with tangles of protein known as tau, form in the brain and grow in number, eventually getting in the way of the brain's ability to function.
› Verified 9 days ago
Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043378656 PECOS PAC ID: 3779495858 Enrollment ID: O20080519000558 |
News Archive
Researchers have developed a method by which thousands of men with prostate cancer could choose their own treatment.
According to a recent analysis by SDI, a leading healthcare market insight and analytics firm, about half of patients beginning therapy on popular osteoporosis drugs discontinue their treatment within 6 months. Amgen's Prolia, which was recently approved for postmenopausal women with osteoporosis at high risk of fracture, or patients who could not tolerate other osteoporosis therapies, is the newest product to enter the market. Prolia differs from existing therapies as it is given every 6 months via injection.
A familiar critique of liberal governance is that the results always matter less than its grand social ambitions. The latest evidence of this truth comes in the reaction to disappointing new findings from one of the most important public-policy experiments since the 1970s. A team of varsity health economists, mostly at Harvard and MIT, is studying the relationship between health outcomes and health insurance delivered by Medicaid (5/2).
The U.S. Food and Drug Administration today warned four companies that the caffeine added to their malt alcoholic beverages is an "unsafe food additive" and said that further action, including seizure of their products, is possible under federal law.
Long before symptoms of Alzheimer's disease become apparent to patients and their families, biological changes are occurring within the brain. Amyloid plaques, which are clusters of protein fragments, along with tangles of protein known as tau, form in the brain and grow in number, eventually getting in the way of the brain's ability to function.
› Verified 9 days ago
Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
---|---|
Entity Type | Part B Supplier - Ambulatory Surgical Center |
Entity Identifiers | NPI Number: 1942546486 PECOS PAC ID: 3779495858 Enrollment ID: O20141111002041 |
News Archive
Researchers have developed a method by which thousands of men with prostate cancer could choose their own treatment.
According to a recent analysis by SDI, a leading healthcare market insight and analytics firm, about half of patients beginning therapy on popular osteoporosis drugs discontinue their treatment within 6 months. Amgen's Prolia, which was recently approved for postmenopausal women with osteoporosis at high risk of fracture, or patients who could not tolerate other osteoporosis therapies, is the newest product to enter the market. Prolia differs from existing therapies as it is given every 6 months via injection.
A familiar critique of liberal governance is that the results always matter less than its grand social ambitions. The latest evidence of this truth comes in the reaction to disappointing new findings from one of the most important public-policy experiments since the 1970s. A team of varsity health economists, mostly at Harvard and MIT, is studying the relationship between health outcomes and health insurance delivered by Medicaid (5/2).
The U.S. Food and Drug Administration today warned four companies that the caffeine added to their malt alcoholic beverages is an "unsafe food additive" and said that further action, including seizure of their products, is possible under federal law.
Long before symptoms of Alzheimer's disease become apparent to patients and their families, biological changes are occurring within the brain. Amyloid plaques, which are clusters of protein fragments, along with tangles of protein known as tau, form in the brain and grow in number, eventually getting in the way of the brain's ability to function.
› Verified 9 days ago
Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
---|---|
Entity Type | Part B Supplier - Ambulatory Surgical Center |
Entity Identifiers | NPI Number: 1457023616 PECOS PAC ID: 3779495858 Enrollment ID: O20220105001262 |
News Archive
Researchers have developed a method by which thousands of men with prostate cancer could choose their own treatment.
According to a recent analysis by SDI, a leading healthcare market insight and analytics firm, about half of patients beginning therapy on popular osteoporosis drugs discontinue their treatment within 6 months. Amgen's Prolia, which was recently approved for postmenopausal women with osteoporosis at high risk of fracture, or patients who could not tolerate other osteoporosis therapies, is the newest product to enter the market. Prolia differs from existing therapies as it is given every 6 months via injection.
A familiar critique of liberal governance is that the results always matter less than its grand social ambitions. The latest evidence of this truth comes in the reaction to disappointing new findings from one of the most important public-policy experiments since the 1970s. A team of varsity health economists, mostly at Harvard and MIT, is studying the relationship between health outcomes and health insurance delivered by Medicaid (5/2).
The U.S. Food and Drug Administration today warned four companies that the caffeine added to their malt alcoholic beverages is an "unsafe food additive" and said that further action, including seizure of their products, is possible under federal law.
Long before symptoms of Alzheimer's disease become apparent to patients and their families, biological changes are occurring within the brain. Amyloid plaques, which are clusters of protein fragments, along with tangles of protein known as tau, form in the brain and grow in number, eventually getting in the way of the brain's ability to function.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Lysa Charles, MD 2101 E Jefferson St Ppqa Medicare Compliance Unt 6 West, Kaiser Permanente Mid Atlantic Permanente Medical Group, Rockville, MD 20852-4908 Ph: (301) 816-6660 | Dr Lysa Charles, MD 2101 E Jefferson St Ppqa Medicare Compliance Unt 6 West, Kaiser Permanente Mid Atlantic Permanente Medical Group, Rockville, MD 20852-4908 Ph: (301) 816-6660 |
News Archive
Researchers have developed a method by which thousands of men with prostate cancer could choose their own treatment.
According to a recent analysis by SDI, a leading healthcare market insight and analytics firm, about half of patients beginning therapy on popular osteoporosis drugs discontinue their treatment within 6 months. Amgen's Prolia, which was recently approved for postmenopausal women with osteoporosis at high risk of fracture, or patients who could not tolerate other osteoporosis therapies, is the newest product to enter the market. Prolia differs from existing therapies as it is given every 6 months via injection.
A familiar critique of liberal governance is that the results always matter less than its grand social ambitions. The latest evidence of this truth comes in the reaction to disappointing new findings from one of the most important public-policy experiments since the 1970s. A team of varsity health economists, mostly at Harvard and MIT, is studying the relationship between health outcomes and health insurance delivered by Medicaid (5/2).
The U.S. Food and Drug Administration today warned four companies that the caffeine added to their malt alcoholic beverages is an "unsafe food additive" and said that further action, including seizure of their products, is possible under federal law.
Long before symptoms of Alzheimer's disease become apparent to patients and their families, biological changes are occurring within the brain. Amyloid plaques, which are clusters of protein fragments, along with tangles of protein known as tau, form in the brain and grow in number, eventually getting in the way of the brain's ability to function.
› Verified 9 days ago
Dr. Neil J Barkin, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 6000 Executive Blvd, Suite 510, Rockville, MD 20852 Phone: 301-770-7900 Fax: 301-770-7904 | |
Ms. Audrey K Tsao, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2101 E Jefferson St, Ste 100, Rockville, MD 20852 Phone: 602-616-1434 | |
Adedapo Ajayi, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 9601 Blackwell Rd Ste 100, Rockville, MD 20850 Phone: 301-940-9200 | |
Dr. Leo M Rozmaryn, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 14995 Shady Grove Rd Ste 350, Rockville, MD 20850 Phone: 301-251-1433 Fax: 301-424-5266 | |
Dr. David Andrew Levin, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 14995 Shady Grove Rd Ste 350, Rockville, MD 20850 Phone: 301-251-1433 Fax: 301-251-2768 | |
Stephen J Rockower, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 6000 Executive Blvd, Suite 510, Rockville, MD 20852 Phone: 301-770-7900 Fax: 301-770-7904 | |
Dr. Barry Paul Boden, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 14995 Shady Grove Rd Ste 350, Rockville, MD 20850 Phone: 301-251-1433 Fax: 301-424-5266 |